Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $26.44, demonstrating a -2.4% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.54%. Elsewhere, the Dow gained 1.05%, while the tech-heavy Nasdaq added 0.56%.
Shares of the company witnessed a loss of 18.92% over the previous month, trailing the performance of the Medical sector with its loss of 1.89%, and the S&P 500's gain of 0.74%.
The investment community will be closely monitoring the performance of Hims & Hers Health, Inc. in its forthcoming earnings report. On that day, Hims & Hers Health, Inc. is projected to report earnings of $0.04 per share, which would represent a year-over-year decline of 63.64%. Meanwhile, our latest consensus estimate is calling for revenue of $620.41 million, up 28.94% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.5 per share and revenue of $2.35 billion. These totals would mark changes of +85.19% and 0%, respectively, from last year.
Investors might also notice recent changes to analyst estimates for Hims & Hers Health, Inc. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.7% lower within the past month. Currently, Hims & Hers Health, Inc. is carrying a Zacks Rank of #4 (Sell).
Digging into valuation, Hims & Hers Health, Inc. currently has a Forward P/E ratio of 46.69. This denotes a premium relative to the industry average Forward P/E of 25.72.
It's also important to note that HIMS currently trades at a PEG ratio of 4.46. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical Info Systems industry had an average PEG ratio of 2.25 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 97, which puts it in the top 40% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hims & Hers Health, Inc. (HIMS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
